Return On Equity of AVADEL PHARMACEUTICALS PLC from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
AVADEL PHARMACEUTICALS PLC quarterly and annual Return On Equity in % history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • AVADEL PHARMACEUTICALS PLC Return On Equity for the quarter ending 30 Sep 2025 was 23%.
  • AVADEL PHARMACEUTICALS PLC annual Return On Equity for 2024 was -66%, a 69% increase from 2023.
  • AVADEL PHARMACEUTICALS PLC annual Return On Equity for 2023 was -212%, a 93% increase from 2022.
  • AVADEL PHARMACEUTICALS PLC annual Return On Equity for 2022 was -3002%, a 4099% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 23% +117% 01 Jul 2025 30 Sep 2025
Q2 2025 -4% +119% +97% 01 Apr 2025 30 Jun 2025
Q1 2025 -36% +113% +76% 01 Jan 2025 31 Mar 2025
Q4 2024 -66% +146% +69% 01 Oct 2024 31 Dec 2024
Q3 2024 -93% +234% +72% 01 Jul 2024 30 Sep 2024
Q2 2024 -123% +677% +85% 01 Apr 2024 30 Jun 2024
Q1 2024 -150% -905% -120% 01 Jan 2024 31 Mar 2024
Q4 2023 -212% +2791% +93% 01 Oct 2023 31 Dec 2023
Q3 2023 -328% +122% +27% 01 Jul 2023 30 Sep 2023
Q2 2023 -800% -565% -241% 01 Apr 2023 30 Jun 2023
Q1 2023 756% +858% 01 Jan 2023 31 Mar 2023
Q4 2022 -3002% -2931% -4099% 01 Oct 2022 31 Dec 2022
Q3 2022 -450% -398% -776% 01 Jul 2022 30 Sep 2022
Q2 2022 -234% -196% -516% 01 Apr 2022 30 Jun 2022
Q1 2022 -103% -99% -2919% 01 Jan 2022 31 Mar 2022
Q4 2021 -72% -77% -1493% 01 Oct 2021 31 Dec 2021
Q3 2021 -51% -69% -394% 01 Jul 2021 30 Sep 2021
Q2 2021 -38% -85% -182% 01 Apr 2021 30 Jun 2021
Q1 2021 -3% -205% -102% 01 Jan 2021 31 Mar 2021
Q4 2020 5% -154% -97% 01 Oct 2020 31 Dec 2020
Q3 2020 17% -715% -98% 01 Jul 2020 30 Sep 2020
Q2 2020 47% +1031% 01 Apr 2020 30 Jun 2020
Q1 2020 201% +481% 01 Jan 2020 31 Mar 2020
Q4 2019 159% +322% 01 Oct 2019 31 Dec 2019
Q3 2019 732% +782% 01 Jul 2019 30 Sep 2019
Q2 2019 -984% -981% -38030% 01 Apr 2019 30 Jun 2019
Q1 2019 -280% -314% -901% 01 Jan 2019 31 Mar 2019
Q4 2018 -163% -249% -290% 01 Oct 2018 31 Dec 2018
Q3 2018 -50% -169% -142% 01 Jul 2018 30 Sep 2018
Q2 2018 -3% -76% -103% 01 Apr 2018 30 Jun 2018
Q1 2018 35% +55% 01 Jan 2018 31 Mar 2018
Q4 2017 86% +168% 01 Oct 2017 31 Dec 2017
Q3 2017 118% +67% +132% 01 Jul 2017 30 Sep 2017
Q2 2017 74% 01 Apr 2017 30 Jun 2017
Q1 2017 -20% 01 Jan 2017 31 Mar 2017
Q4 2016 -82% 01 Oct 2016 31 Dec 2016
Q3 2016 51% 01 Jul 2016 30 Sep 2016
Q2 2015 -170% +5% +2.8% 01 Apr 2015 30 Jun 2015
Q1 2015 -130% +424% +77% 01 Jan 2015 31 Mar 2015
Q4 2014 -170% 01 Oct 2014 31 Dec 2014
Q3 2014 -126% 01 Jul 2014 30 Sep 2014
Q2 2014 -175% 01 Apr 2014 30 Jun 2014
Q1 2014 -554% 01 Jan 2014 31 Mar 2014

AVADEL PHARMACEUTICALS PLC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -66% +146% +69% 01 Jan 2024 31 Dec 2024
2023 -212% +2791% +93% 01 Jan 2023 31 Dec 2023
2022 -3002% -2931% -4099% 01 Jan 2022 31 Dec 2022
2021 -72% -77% -1493% 01 Jan 2021 31 Dec 2021
2020 5% -154% -97% 01 Jan 2020 31 Dec 2020
2019 159% +322% 01 Jan 2019 31 Dec 2019
2018 -163% -249% -290% 01 Jan 2018 31 Dec 2018
2017 86% +168% 01 Jan 2017 31 Dec 2017
2016 -82% 01 Jan 2016 31 Dec 2016
2014 -170% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.